Matches in Wikidata for { <http://www.wikidata.org/entity/Q61904763> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- Q61904763 description "assaig clínic" @default.
- Q61904763 description "clinical trial" @default.
- Q61904763 description "clinical trial" @default.
- Q61904763 description "clinical trial" @default.
- Q61904763 description "clinical trial" @default.
- Q61904763 description "ensaio clínico" @default.
- Q61904763 description "ensayo clínico" @default.
- Q61904763 description "ensayu clínicu" @default.
- Q61904763 description "essai clinique" @default.
- Q61904763 description "klinisch onderzoek" @default.
- Q61904763 description "клінічне випробування" @default.
- Q61904763 name "Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)" @default.
- Q61904763 type Item @default.
- Q61904763 label "Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)" @default.
- Q61904763 prefLabel "Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)" @default.
- Q61904763 P1050 Q61904763-7F4A1F79-6777-4C50-8E8F-B1F2188154D1 @default.
- Q61904763 P1050 Q61904763-A836F695-1F4B-430C-9801-59CE0BACCA6C @default.
- Q61904763 P1132 Q61904763-8C5D9C3C-EBDE-4510-8704-6C67B2F384E6 @default.
- Q61904763 P1476 Q61904763-488079E6-9890-4454-859C-96F363EF27FC @default.
- Q61904763 P17 Q61904763-085CB842-68FD-4E59-B3BE-5D65CD433500 @default.
- Q61904763 P1813 Q61904763-EA113615-9E6A-4311-B0CE-EC637DABC52E @default.
- Q61904763 P2899 Q61904763-72FE7B88-43EE-45C0-9217-DF6AD78C412C @default.
- Q61904763 P3098 Q61904763-BBA93221-30F0-4CBE-8287-63E923F73D75 @default.
- Q61904763 P31 Q61904763-97F4BC49-F163-4C12-BBAA-C38D073B3760 @default.
- Q61904763 P4135 Q61904763-62705339-9A24-4AD3-94C7-3FD33E98E302 @default.
- Q61904763 P580 Q61904763-437B4F25-1D54-4168-817C-A2D49A7AB6C6 @default.
- Q61904763 P582 Q61904763-4852CE07-C06A-4FB9-8BED-6477A0BAA7B4 @default.
- Q61904763 P6099 Q61904763-2B0E5CC1-0691-4120-BE25-61655307EF61 @default.
- Q61904763 P6153 Q61904763-13C14346-45C2-46DD-A5CC-6795D8855304 @default.
- Q61904763 P6153 Q61904763-2D339527-8F02-4E44-8128-0828ABE3A06B @default.
- Q61904763 P6153 Q61904763-2F5803D4-77FA-4796-A258-D0CB53250D32 @default.
- Q61904763 P6153 Q61904763-5B190F7E-CC4C-4789-9004-16F374A7F038 @default.
- Q61904763 P6153 Q61904763-6891E132-0A75-49A7-8B70-8FF8C9EFDBC6 @default.
- Q61904763 P6153 Q61904763-6DA6F636-2E0C-4DA1-9B50-DF4864F81CDA @default.
- Q61904763 P6153 Q61904763-7CC2C886-0288-4FA4-96EB-FD3061128CDB @default.
- Q61904763 P6153 Q61904763-8A09C17E-B850-48FD-829E-BD24F01D638C @default.
- Q61904763 P6153 Q61904763-9514745E-47F1-4EA8-AD70-46214ACFF201 @default.
- Q61904763 P6153 Q61904763-9BE59837-BD87-4A9B-977E-5EF4660F45C3 @default.
- Q61904763 P6153 Q61904763-9F6FE8AB-8F89-4B7E-8DDD-222D92711251 @default.
- Q61904763 P6153 Q61904763-A9B83F1D-77FA-477D-9921-086916C173A2 @default.
- Q61904763 P6153 Q61904763-AC44BC4A-ADBF-4F77-896A-35E760207DBB @default.
- Q61904763 P6153 Q61904763-AC527A22-D095-4383-80FE-4E1081D6DD6D @default.
- Q61904763 P6153 Q61904763-B7C9E700-9EF1-4E32-96DF-267191D922A6 @default.
- Q61904763 P6153 Q61904763-DA0957C2-B7AC-435E-B3CB-1C016FBEB6C8 @default.
- Q61904763 P6153 Q61904763-E3BD9E98-8A1E-47E2-9AC1-FA4EDBAC029C @default.
- Q61904763 P6153 Q61904763-EE31A4EA-3D38-4ED4-8C03-35587B4B5D95 @default.
- Q61904763 P6153 Q61904763-F8B00B9A-84CA-48DB-936C-46299224F820 @default.
- Q61904763 P6153 Q61904763-F8B56AFA-45C0-4777-B583-7F304939D1C2 @default.
- Q61904763 P8363 Q61904763-CAC8B5A8-5404-4B52-862C-4F73BADA3BA1 @default.
- Q61904763 P1050 Q615363 @default.
- Q61904763 P1050 Q906492 @default.
- Q61904763 P1132 "+350" @default.
- Q61904763 P1476 "A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)" @default.
- Q61904763 P17 Q30 @default.
- Q61904763 P1813 "ASPEN-OLS" @default.
- Q61904763 P2899 "+18" @default.
- Q61904763 P3098 "NCT03617367" @default.
- Q61904763 P31 Q30612 @default.
- Q61904763 P4135 "+80" @default.
- Q61904763 P580 "2018-09-05T00:00:00Z" @default.
- Q61904763 P582 "2021-11-30T00:00:00Z" @default.
- Q61904763 P6099 Q42824827 @default.
- Q61904763 P6153 Q1057447 @default.
- Q61904763 P6153 Q149990 @default.
- Q61904763 P6153 Q1535116 @default.
- Q61904763 P6153 Q168751 @default.
- Q61904763 P6153 Q180865 @default.
- Q61904763 P6153 Q270222 @default.
- Q61904763 P6153 Q2892284 @default.
- Q61904763 P6153 Q30269612 @default.
- Q61904763 P6153 Q30270266 @default.
- Q61904763 P6153 Q30289331 @default.
- Q61904763 P6153 Q49117 @default.
- Q61904763 P6153 Q50036718 @default.
- Q61904763 P6153 Q5903033 @default.
- Q61904763 P6153 Q621043 @default.
- Q61904763 P6153 Q64443878 @default.
- Q61904763 P6153 Q738258 @default.
- Q61904763 P6153 Q777403 @default.
- Q61904763 P6153 Q7895888 @default.
- Q61904763 P6153 Q7914455 @default.
- Q61904763 P6153 Q911561 @default.
- Q61904763 P8363 Q78089383 @default.